NAV Per Share: ZAc 521 (as at 31 December 2018)
Major Shareholders
Current Shares In Issue: 1,410,618,800
| Shareholders holding 5% or more | Number of shares | % |
|---|---|---|
| Dr Christo Wiese1 | 160,388,407 | 11.37 |
| Fidelity International | 142,168,555 | 10.08 |
| NGPMR (Cayman) L.P. | 138,469,735 | 9.82 |
| Ophorst Van Marwijk Kooy Vermogensbeheer N.V. | 104,698,572 | 7.42 |
| Gemfields Group Limited2 | 96,276,146 | 6.83 |
| Oasis3 | 94,785,218 | 6.72 |
1 Dr Wiese holds indirect interests in GGL shares via various entities, totalling 11.37%. In addition, certain shares are held by members of Dr Wiese’s immediate family, totalling a further 0.16%.
2 The Company’s interest in its own shares is 96,276,146 or 6.83%.
3 The Oasis shareholding includes interests held by Oasis Asset Management and Oasis Crescent Capital.
4 Shareholdings are accurate as at 31 March 2019, source: Nasdaq.
5 The Company had repurchased 21,066,753 of its own shares during 2017/2018, these shares have now been cancelled bringing the Company’s shares in issue to 1,410,618,800 as at 15 May 2019.